Rater Training

What We Believe

MedAvante-ProPhase exists to help unlock new and better treatments through smarter, faster clinical trials.

We believe data will transform the way the world understands health and medicine, greatly improving the way potential treatments are tested.

Our mission is to apply deep scientific expertise to optimizing the quality of clinical trial outcome data. We will do this with cohesive, interoperable software and accurate, precise clinician services that work together to improve the collection, management and analysis of clinical study data.

Why MedAvante-ProPhase?

To improve the ability to detect a signal of efficacy in a clinical trial and reduce the risk of inconclusive results, drug developers, study teams and research clinicians need a capable and trusted global partner.

MedAvante-ProPhase is a clinical data sciences company providing science-driven, technology-enabled clinical measurement and signal detection solutions with a history of proven innovation.

Our clinical expertise and record of combining scientific innovation with digital capabilities is rooted in years of experience working with some of the most challenging of clinical trial outcomes – Central Nervous System (CNS) disorders.

The Virgil Investigative Study Platform, paired with our suite of clinician services, make MedAvante-ProPhase the most proficient and reliable global partner for improved signal detection and smarter, faster clinical trials.

Why Virgil?

Virgil was created by clinicians, for clinicians.Virgil addresses the real needs of raters and coordinators, and reduces process complexity and administrative burden for sites.

Virgil amplifies the power of MedAvante-ProPhase clinician services as the digital platform delivering Independent Ratings and Independent Review with the same timely results and data quality, eliminating paper and increasing strategic options for a smarter trial.

"The Virgil software and tablet is pretty amazing. It’s the most user/site friendly we have used for clinical trials and we have used several. The software mimics writing on paper extremely well, and we appreciate that there wasn’t any skimping in the processor speed. The Virgil tablet has gained some big fans at our site."

— Principal Investigator, USA

"The industry is hungry for innovation. And they’re hungry for innovation because the current models are struggling."

— Senior executive, large pharma

"Our team finds the tablets operating on the Virgil system very user-friendly
very easy to get used to and really straight forward to work with. It is fast and properly responsive to our inputs, stylus use is similar to using a normal pen and paper set-up. All in all, the Virgil system is our favourite system to work with!"

— Principal Investigator, EU

"Losing patient data can be tragic. I look very carefully at data loss rates because I want them to be 0.01% or 0%. I cannot afford to lose data. The loss rates are a way that I differentiate one provider from another."

— Senior executive, biotech

"The Virgil tablet and its well-designed digital scales improve our ability to administer quality assessment by being easy-to-use and helpful to our raters. We like the way recordings are collected and appreciate the convenience of handling them with no additional steps for our team to perform… We have had a very good experience with the Virgil platform and we recommend its use to any clinical trial sponsor."

— Principal Investigator, USA

Our approach

We design with a clinician’s brain and a startup’s heart. Created by clinicians for clinicians, Virgil provides built-in clinical guidance to help standardize assessments and increase the quality of trial results.

How we help

We provide clinicians and researchers with the tools, data-driven insights, and guidance they need to get their work done more easily and efficiently.